Publications by authors named "Quanjun Fang"

Objectives: To investigate the factors influencing SARS-CoV-2 IgG antibody levels and protection in a population that has experienced both vaccination and COVID-19 infections, predominantly caused by the Omicron BA.5.2 and BF.

View Article and Find Full Text PDF

Despite the implementation of a two-dose varicella vaccine (VarV) immunization strategy for over a decade in Quzhou, China, outbreaks of varicella continue to be reported in school settings with high vaccination coverage. This cross-sectional study surveyed healthy individuals aged 3 to 20 years across six districts and counties in Quzhou, China. Serum samples were collected to detect varicella-zoster virus (VZV) IgG antibodies and to evaluate the effectiveness of the two-dose VarV immunization strategy.

View Article and Find Full Text PDF

The aim of this study was to ascertain the current status of healthcare workers' (HCWs) willingness to receive the influenza vaccination and to identify the influencing factors in Quzhou. A self-administered questionnaire was used to investigate the cognition and vaccination intention of in-service HCWs in 10 medical and health institutions in Quzhou from July to September in 2022, and the influencing factors of vaccination intention were analyzed by Logistic regression. A total of 228 questionnaires were returned, with the effective rate of 95.

View Article and Find Full Text PDF

Background: HFMD is a common infectious disease that is prevalent worldwide. In many provinces in China, there have been outbreaks and epidemics of whooping cough, posing a threat to public health.

Purpose: It is crucial to grasp the epidemiological characteristics of HFMD in Quzhou and establish a prediction model for HFMD to lay the foundation for early warning of HFMD.

View Article and Find Full Text PDF
Article Synopsis
  • Quzhou City has transitioned from DTwP to DTaP vaccines with a high vaccination rate of 99%, yet a resurgence of pertussis cases has occurred, particularly in early 2024.
  • Data showed a significant spike in pertussis cases concentrated in the central region, mostly affecting children aged 5-9 years old.
  • A survival analysis indicated that those who received self-paid vaccines were 2.84 times more likely to contract pertussis compared to those who received free vaccines, highlighting the urgent need for improved immunization strategies.
View Article and Find Full Text PDF

Background: Implementing hepatitis B vaccination is an important strategy to reduce hepatitis B virus infection and disease burden. Suboptimal adult hepatitis B vaccination coverage limits the further reduction of hepatitis B virus infection.

Methods: A multistage stratified random sampling method was adopted to survey the permanent population aged 1-59 in 2006 and 2024.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the epidemiological characteristics and incidence of mumps in Quzhou from 2005 to 2023, focusing on the effects of various mumps vaccination strategies.
  • A total of 10,295 mumps cases were reported, with the highest incidence noted during the one-dose vaccination period (57.5/100,000), which significantly dropped to 6/100,000 after implementing two doses of the vaccine.
  • The findings highlighted that the two-dose MuCV vaccination was effective in reducing mumps cases, especially among children aged 5-9 years, stressing the need for high vaccination rates to control outbreaks in schools.
View Article and Find Full Text PDF
Article Synopsis
  • Hepatitis B vaccination is highly effective in preventing HBV transmission, but monitoring and reporting adverse events following immunization (AEFI) is essential for safety.
  • A study in Quzhou from 2011 to 2023 analyzed AEFI reporting rates, symptoms, and onset times, finding a reporting rate of 17.55 AEFI per 100,000 doses, with the majority being non-serious.
  • The research showed that AEFI were mostly related to vaccine product reactions and common symptoms included fever and local site reactions; it also noted that AEFI rates were higher for the CHO vaccine compared to yeast vaccines, especially in children under one year old receiving subsequent doses.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed 1,291 varicella cases from children born between 2009 and 2014, finding that vaccination improvements shifted the average age of infection to 9-11 years old.
  • * The study concluded that a two-dose vaccination strategy significantly reduced the risk of varicella infection in children and recommended the inclusion of this regimen in the national immunization schedule.
View Article and Find Full Text PDF
Article Synopsis
  • Mumps is an infectious disease that can be prevented by vaccination, and its incidence was analyzed in Quzhou City after the introduction of the MMR vaccine.
  • Despite a significant reduction in mumps cases over 15 years, the highest incidence was still found in vaccinated children aged 0-12, possibly due to vaccine escape.
  • The study suggests that existing vaccines may need updates or new development to target multiple viral strains for better control, as antibody levels do not reliably indicate immunity or protection against mumps.
View Article and Find Full Text PDF
Article Synopsis
  • This study evaluated the effectiveness of different hepatitis B vaccine strategies four years after immunization in children who were negative for hepatitis B surface antigen (HBsAg).
  • It involved analyzing the antibody responses of 359 children who received various dosages and combinations of the Hansenulapolymorpha recombinant hepatitis B vaccine (HepB-HP) and Chinese hamster ovary cell HepB (HepB-CHO) at different ages.
  • The results indicated that higher doses of HepB-CHO resulted in better antibody concentrations and seropositivity rates compared to lower doses, suggesting that future immunization strategies could benefit from using the 20 μg HepB-CHO for increased effectiveness.
View Article and Find Full Text PDF

Rubella is a major cause of congenital defects, and the presence of rubella infection in a pregnant woman may lead to fetal death or congenital defects known as congenital rubella syndrome(CRS). Since China has not yet established a national CRS surveillance system, the true incidence cannot be determined. To understand the disease burden and epidemiological characteristics of CRS cases in China, the article reports the first case of CRS in Quzhou, China, and conducts a retrospective analysis of related cases that have been reported in China over the past decade.

View Article and Find Full Text PDF

Limited data are available on the effectiveness of COVID-19 vaccines used in China in real-world outbreaks - especially against Omicron variants in vaccinated individuals. Two outbreaks of SARS-CoV-2 Omicron variants - the first involving the sub-lineage BA.2 and the second the BA.

View Article and Find Full Text PDF
Article Synopsis
  • High-income countries are experiencing a resurgence of pertussis (whooping cough) despite high vaccination rates, leading to a need for reevaluation of vaccine strategies.
  • A study involving 953 children compared the immune responses to two types of acellular vaccines: component and co-purified, finding that the component vaccine produced higher levels of pertussis antibodies initially.
  • Antibody levels decreased over time for both vaccine types, highlighting the importance of developing more effective pertussis vaccines and recommending booster doses for various age groups.
View Article and Find Full Text PDF

Mumps cases were reported frequently when a routine dose measles-mumps-rubella(MMR) achieved high coverage in Quzhou. The supplementary immunization activities (SIA) using measles mumps (MM) was conducted to control mumps outbreaks. The effectiveness of one and two doses of mumps-containing vaccine (MuCV) was assessed using surveillance data in this study.

View Article and Find Full Text PDF

Mumps is a vaccine-preventable disease caused by the mumps virus, but the incidence of mumps has increased among the children who were vaccinated with one-dose measles-mumps-rubella (MMR) in recent years. In this study, we analyzed the influence of different doses of mumps-containing vaccine (MuCV) against mumps using Cox-proportional hazard model. We collected 909 mumps cases of children who were born from 2006 to 2010 and vaccinated with different doses of MuCV in Quzhou during 2006-2018, which were all clinically diagnosed.

View Article and Find Full Text PDF

Background: From 2005 to 2016, the prevention and control of mumps in China have undergone three stages of transition. These include the use of MuCV as a self-supported vaccine, the introduction of one-dose MMR to the Expanded Program on Immunization (EPI), and the administration of two-dose MuCV following supplementary immunization activities (SIAs) using MM. Here, using surveillance data, we assessed the epidemiology of mumps during the three stages.

View Article and Find Full Text PDF